President and Chief Executive Officer · Xtant Medical Holdings, Inc. (XTNT)

Sean Browne

A named executive officer of Xtant Medical in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,351,676

Salary $624,000Stock awards $588,812Bonus $100,000

FY2024: $2,461,736

1st of 3 named executive officers at Xtant Medical by FY2025 total.

3 named officers on file for Xtant Medical, FY2025

Sean Browne’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Xtant Medical’s whole pay program stands against its peers

  • Xtant Medical’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on XTNT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 23, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Sean Browne’s full pay file as a PDF — free

More than this page: up to 10 years of Sean’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Sean Browne compensation by year

Xtant Medical Summary Compensation Table · all 2 fiscal years held
In US dollars, as Xtant Medical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$617,539$624,000
Bonus$0$100,000
Stock awards$1,807,132$588,812
Option awards$0$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$37,065$38,864
Total$2,461,736$1,351,676

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Xtant Medical Holdings, Inc. DEF 14A filed June 23, 2026, accession 0001493152-26-029699, and prior-year filings.

How this page was built: the Xtant Medical Holdings, Inc. filed document, accession 0001493152-26-029699. Every figure is read from that document and cited to the page and table it appears in. Filed June 23, 2026.

$2.5M
$1.4M
FY24
FY25
SalaryBonusStock awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU548,724$428,005—
RSU394,937$308,051—
PSU365,816$285,336—
RSU87,108$67,944—
PSU34,994$27,295—
Option88,923—$1.20

Per the Outstanding Equity Awards at Fiscal Year-End table in Xtant Medical Holdings, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

2 Form 4 lines since the FY2025 proxy (filed June 23, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-15Tax withholding—10,605$0.313,114,669
2026-08-15Grant or award—550,000$0.003,125,274

The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Xtant Medical’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Sean Browne · this pagePresident and Chief Executive Officer$1,351,676
Mark SchallenbergerChief Operating Officer$1,110,531
Scott NeilsChief Financial Officer$939,369

The full Xtant Medical compensation record

free company brief

This page is one person within Xtant Medical's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Xtant Medical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sean Browne's compensation dossier · One-time report. No refunds.